Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 175CNS 120Genitourinary 89Head & Neck 85Thoracic 77Sarcoma 66Breast 57Lymphoid 49Gynecologic 42Other hematologic neoplasm 31Dermatologic 26Tumor-Agnostic 12Other solid neoplasm 10Myeloid 7Plasma cell 6Other 5Endocrine 3NET 1Classical hematology 1

Conditions

Lymphoma, Follicular 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 93fludarabine phosphate 86Busulfan 63Cyclosporine 57Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53Epoetin Alfa 53Antilymphocyte Serum 43fludarabine 42Filgrastim 41Cytarabine 41Tacrolimus 39Melphalan 38Darbepoetin alfa 38Methotrexate 34Radiotherapy 32Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23Methylprednisolone 21Etoposide 21apixaban 18eltrombopag 16Thiotepa 16Dalteparin 16ferric carboxymaltose 14Daunorubicin 14Azacitidine 14Alemtuzumab 14thymoglobulin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiation × Classical hematology × Clear all
NCT00578903 2016-04-22

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Baylor College of Medicine

Phase 2 Terminated
22 enrolled 11 charts
Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡